Patents by Inventor Areet Krsna Ganesh Shermon

Areet Krsna Ganesh Shermon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aptamer bioconjugate drug delivery device
    Patent number: 11369570
    Abstract: A delivery device for a active agent comprises nanoparticles based on a biopolymer such as starch. The delivery device may also be in the form of an aptamer-biopolymer-active agent conjugate wherein the aptamer targets the device for the treatment of specific disorders, such as cancer. The delivery device survives for a period of time in the body sufficient to allow for transport and uptake of the delivery device into targeted cells. The degree of crosslinking can provide a desired release profile of the active agent at, near or inside the target cells. The nanoparticles may be made by applying a high shear force in the presence of a cross linker. The particles may be predominantly in the range of 50-150 nm and form a colloidal dispersion of crosslinked hydrogel particles in water.
    Type: Grant
    Filed: September 21, 2012
    Date of Patent: June 28, 2022
    Assignee: GREENMARK BIOMEDICAL INC.
    Inventors: Steven Bloembergen, Ian J. McLennan, Nathan Jones, Areet Krsna Ganesh Shermon, Abdel Elsayed, Juewen Liu
  • APTAMER BIOCONJUGATE DRUG DELIVERY DEVICE
    Publication number: 20150025029
    Abstract: A delivery device for a active agent comprises nanoparticles based on a biopolymer such as starch. The delivery device may also be in the form of an aptamer-biopolymer-active agent conjugate wherein the aptamer targets the device for the treatment of specific disorders, such as cancer. The delivery device survives for a period of time in the body sufficient to allow for transport and uptake of the delivery device into targeted cells. The degree of crosslinking can provide a desired release profile of the active agent at, near or inside the target cells. The nanoparticles may be made by applying a high shear force in the presence of a cross linker. The particles may be predominantly in the range of 50-150 nm and form a colloidal dispersion of crosslinked hydrogel particles in water.
    Type: Application
    Filed: September 21, 2012
    Publication date: January 22, 2015
    Inventors: Steven Bloembergen, Ian J. McLennan, Nathan Jones, Areet Krsna Ganesh Shermon, Abdel Elsayed, Juewen Liu